Sean F. Scanlan - 08 Mar 2026 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Innovation Officer
Signature
/s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan
Issuer symbol
TMCI
Transactions as of
08 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 21:00:06 UTC
Previous filing
11 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Scanlan Sean F. Chief Innovation Officer C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan 11 Mar 2026 0001856371

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Tax liability -401 -0.06% $0.000000* 706,073 08 Mar 2026 Direct F1
transaction TMCI Common Stock Tax liability -1,396 -0.2% $0.000000* 704,677 10 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 509,648 restricted stock units.
F2 Includes 503,917 restricted stock units.